Kent Lake Capital LLC’s Halozyme Therapeutics Inc Position
Does Kent Lake Capital LLC own Halozyme Therapeutics Inc (HALO)? Not currently — the last reported position was 60.0K shares worth $2M in Q4 2021; the fund’s latest 13F (Q2 2024) no longer reports it.
Position Value
$2M
Q4 2021
Shares
60.0K
% of Portfolio
+1.25%
Quarters Held
3
position exited
Position History HALO
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Kent Lake Capital LLC’s full portfolio or all institutional holders of HALO.